Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia.
Neuropsychiatr Dis Treat
; 15: 2073-2085, 2019.
Article
en En
| MEDLINE
| ID: mdl-31410011
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Neuropsychiatr Dis Treat
Año:
2019
Tipo del documento:
Article